Search results for "Lung neoplasms"

showing 10 items of 432 documents

The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells

2007

Cancer development can be viewed as dysregulated repair. Antimicrobial peptides (AMPs) are effector molecules of the innate immune system with direct antimicrobial activity. Beside this host defence function several AMPs play a role in the regulation of inflammation and tissue repair. The aim of the present study was to investigate whether the human cathelicidin AMP LL-37/hCAP-18 is involved in the biology of lung cancer. Human cancer cell lines were found to express the human cathelicidin LL-37/hCAP-18 mRNA and peptide at different levels. Immunohistochemistry of human lung cancers showed that the peptide is expressed mostly in adenocarcinoma and squamous cell carcinoma. Application of exo…

Pulmonary and Respiratory MedicineCancer ResearchLung Neoplasmsmedicine.medical_treatmentMice NudeBiologyCathelicidinMiceCathelicidinsCell Line TumormedicineAnimalsHumansRNA MessengerEpidermal growth factor receptorGrowth SubstancesLung cancerMice Inbred BALB CInnate immune systemCell growthGrowth factorCancermedicine.diseaseErbB ReceptorsOncologyCell cultureImmunologyCancer researchbiology.proteinFemaleAntimicrobial Cationic PeptidesSignal TransductionLung Cancer
researchProduct

Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients.

2014

Lung cancer is the most common cancer-related death worldwide. In Germany it accounts for 25% of cancer deaths in men, and 14% in women. The aim of this study is to provide an overview of 5-year relative survival by sex, age, histology, and tumour stage in Germany representing a population of 26.7 million people.The study is based on a pooled German dataset including data from 12 population-based cancer registries covering around one third of the German population. A total of 132,612 patients diagnosed with lung cancer from 2002 to 2010 were included in the analysis. Survival estimates for the time period 2007-2010 were calculated using period analysis. Differences in survival between sexes…

Pulmonary and Respiratory MedicineGerontologyAdultMaleCancer ResearchLung NeoplasmsAdolescentPopulationAge adjustmentsymbols.namesakeYoung AdultSex FactorsGermanymedicineHumansPoisson regressionRegistrieseducationLung cancerAgedNeoplasm StagingAged 80 and overeducation.field_of_studyRelative survivalbusiness.industryAbsolute risk reductionAge FactorsCancerMiddle Agedmedicine.diseaseCancer registryOncologyPopulation SurveillancesymbolsFemalebusinessDemographyLung cancer (Amsterdam, Netherlands)
researchProduct

Quantitative analysis of airway obstruction in lymphangioleiomyomatosis

2020

Lymphangioleiomyomatosis (LAM) is a rare, cystic lung disease with progressive pulmonary function loss caused by progressively proliferating LAM cells. The degree of airway obstruction has not been well investigated within the pathogenesis of LAM. Using a combination of ex vivo computed tomography (CT), microCT and histology, the site and nature of airway obstruction in LAM explant lungs was compared with matched control lungs (n=5 each). The total number of airways per generation, total airway counts, terminal bronchioles number and surface density were compared in LAM versus control. Ex vivo CT analysis demonstrated a reduced number of airways from generation 7 on (p<0.0001) in LAM compar…

Pulmonary and Respiratory MedicineLipopolysaccharidesPathologymedicine.medical_specialtyLung NeoplasmsPulmonary function testingPathogenesisOrphan Lung Diseases03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineMedicine and Health SciencesFLOW OBSTRUCTIONMedicineHumans030212 general & internal medicineLymphangioleiomyomatosisBronchiolesLungbusiness.industryHistologyOriginal ArticlesX-Ray MicrotomographyAirway obstructionrespiratory systemmedicine.disease133. Good healthrespiratory tract diseasesAirway Obstruction030228 respiratory systemPULMONARY LYMPHANGIOLEIOMYOMATOSISLymphangioleiomyomatosisHuman medicineAirwaybusinessQuantitative analysis (chemistry)Ex vivoCTThe European Respiratory Journal
researchProduct

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

2006

Introduction: Lung cancer is the leading cause of tumour-related deaths in the elderly population but the optimal management of advanced NSCLC in older patients has not been defined to date. The present phase II study was planned to evaluate the efficacy and toxicity of the combination of carboplatin and paclitaxel in elderly patients with advanced NSCLC. Patients and methods: Patients (>70 years old) who had pathologically been proven to have a NSCLC and measurable lesions were treated with paclitaxel (175 mg/m2for 3 h) and carboplatin [area under the concentration-time curve (AUC = 5)] on day 1 every 3 weeks. Results: Forty patients were enrolled into the study. The median age was 74 year…

Pulmonary and Respiratory MedicineMaleCancer Researchmedicine.medical_specialtyLung NeoplasmsPaclitaxelSettore MED/06 - Oncologia Medicamedicine.medical_treatmentPopulationnon-small cell lung cancer (NSCLC)Phases of clinical researchNeutropeniaGastroenterologyCarboplatinchemistry.chemical_compoundElderlyNon-small cell lung cancerInternal medicineCarcinoma Non-Small-Cell LungAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansLung cancereducationAgededucation.field_of_studyChemotherapyAntineoplastic Combined Chemotherapy ProtocolPerformance statusbusiness.industrymedicine.diseaseSurvival AnalysisCarboplatinSurgeryLung NeoplasmTreatment OutcomeOncologychemistryItalyCarboplatin plus paclitaxelFemaleSurvival AnalysibusinessHuman
researchProduct

Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.

2012

OBJECTIVES: The role of radical pleurectomy (RP) in the management of IMIG stage III in malignant pleural mesothelioma (MPM) remains controversial. The aim of the study was to investigate the feasibility and outcome as well as to determine factors predicting poor survival. METHODS: Patients having IMIG stage III MPM were identified within a prospective multimodality treatment study (RP followed by chemoradiation) between 2002 and 2010 at a single institution. Kaplan–Meier analyses, log-rank test and Cox regression analyses were used to estimate survival and to determine predictors of survival. RESULTS: A total of 78 patients (66.3 ± 2.5 years, 65 males) underwent RP followed by chemoradiati…

Pulmonary and Respiratory MedicineMaleMesotheliomamedicine.medical_specialtyLung NeoplasmsKaplan-Meier EstimatemedicineHumansMesotheliomaProgression-free survivalStage (cooking)LungAgedProportional Hazards ModelsUnivariate analysisProportional hazards modelbusiness.industryHazard ratioMesothelioma MalignantGeneral MedicineChemoradiotherapyMiddle Agedmedicine.diseaseSurgeryLog-rank testPleuraSurgeryFemaleCardiology and Cardiovascular MedicinebusinessOrgan Sparing TreatmentsChemoradiotherapyEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Detection of lung cancer with electronic nose and logistic regression analysis.

2018

Lung cancer is a very common malignancy with a low five-year survival rate. Artificial olfactory sensor (electronic nose) is a tool that recently has been studied as a probable optimal screening tool for early detection of lung cancer, but still no statistical method has been put forward as the preferable one. The aim of the study was to explore the use of logistic regression analysis (LRA) to analyse patients' exhaled breath samples with electronic nose in order to differentiate lung cancer patients (regardless of the stage of the cancer) from patients with other lung diseases and healthy individuals. Patients with histologically or cytologically verified, untreated lung cancer, patients w…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyLung NeoplasmsMalignancy01 natural sciencesModels Biological03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansLung cancerElectronic NoseSurvival rateAsthmaAgedLungbusiness.industry010401 analytical chemistryCancerrespiratory systemMiddle Agedmedicine.diseaseHealthy Volunteersrespiratory tract diseases0104 chemical sciencesPneumoniamedicine.anatomical_structureLogistic Models030228 respiratory systemBreath TestsExhalationFemaleSample collectionbusinessJournal of breath research
researchProduct

Current Practices in the Management of Pulmonary Ground-Glass Opacities: A Survey of SICT Members

2018

Background Several gray areas and controversies exist concerning the management of pulmonary ground-glass opacities (GGOs), and there is a lack of consensus among clinicians on this topic. One of the main aims of the Italian Society of Thoracic Surgery is to promote education and research, so we decided to perform a survey on this topic to estimate current trends in practice in a large sample of thoracic surgeons. Methods A total of 160 thoracic surgeons responded, namely, completed our questionnaire (response rate, 53%; 160 of 302). The survey was composed of 36 questions divided into six subsections: (1) demographic characteristics of the respondents; (2) terminology and taxonomy; (3) rad…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyLung NeoplasmsOutcome AssessmentAttitude of Health PersonnelComputed tomographyPractice Patterns030204 cardiovascular system & hematologyRisk AssessmentLung/diagnostic imaging Lung/pathology Lung Neoplasms/diagnostic imaging*Fluorodeoxyglucose positron emission tomography03 medical and health sciences0302 clinical medicineSettore MED/21 - CHIRURGIA TORACICAMedicalSurveys and QuestionnairesOutcome Assessment Health CaremedicineHumansPractice Patterns Physicians'TomographyLungSocieties MedicalSurgeonsPhysicians'medicine.diagnostic_testbusiness.industryGeneral surgeryConsensus conferenceThoracic SurgeryLarge sampleX-Ray ComputedHealth CareItalyCardiothoracic surgery030220 oncology & carcinogenesisHealth Care SurveysPositron-Emission TomographyCell lung-cancer Invasive adenocarcinoma Wedge resection In-situ Classification Association Tomography Lobectomy Diagnosis HistorySurgeryFemaleLung resectionCardiology and Cardiovascular MedicinebusinessSocietiesTomography X-Ray ComputedAttitude of Health Personnel; Female; Health Care Surveys; Humans; Italy; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Practice Patterns Physicians'; Risk Assessment; Societies Medical; Surgeons; Thoracic Surgery; Tomography X-Ray Computed; Outcome Assessment Health Care; Surveys and Questionnaires
researchProduct

Impact of video-assisted thoracic surgery approach on postoperative mortality after lobectomy in octogenarians.

2019

The number of octogenarians who present with localized lung cancer eligible for surgical resection is increasing. Video-assisted thoracic surgery lobectomy has been widely accepted, but the potential benefit in octogenarians is not well established, especially for postoperative mortality. This study aimed to assess the impact of a video-assisted thoracic surgery approach on postoperative mortality after lobectomy for lung cancer in octogenarians.From January 2005 to December 2016, all patients aged more than 80 years who received lobectomy treatment for lung cancer were retrieved from the French Administrative Database. The end point was 30-day postoperative death. A propensity score was ge…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyLung NeoplasmsTime FactorsDatabases Factualmedicine.medical_treatment[SDV]Life Sciences [q-bio]030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsThoracoscopyMedicineHumansThoracotomyLung cancerPneumonectomyComputingMilieux_MISCELLANEOUSAged 80 and overmedicine.diagnostic_testbusiness.industryThoracic Surgery Video-AssistedAge FactorsOdds ratiomedicine.diseaseConfidence intervalSurgeryTreatment Outcome030228 respiratory systemThoracotomyCardiothoracic surgeryPostoperative mortalityPropensity score matchingSurgeryFemaleFranceCardiology and Cardiovascular MedicinebusinessThe Journal of thoracic and cardiovascular surgery
researchProduct

Secondary Carina and Lobar Bronchi Stenting in Patients with Advanced Lung Cancer: Is It Worth the Effort? A Clinical Experience

2020

Background: The lobar airway stenting remains an endoscopic procedure not well standardized in patients with locally advanced lung cancer disease. The goal of this study was to evaluate technical feasibility, clinical outcome, and complications of different stents in patients with malignant lesions involving lobar bronchi, primary and secondary carina. Methods: Between November 2008 and October 2013, we retrospectively analyzed 146 patients with benign and malignant tracheobronchial stenosis who underwent airway stent insertion below main carina and main bronchi. Results: In all, 170 airway stenting procedures were performed on 146 patients. In all, 51 of them with malignant peripheral airw…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentSettore MED/21 - Chirurgia ToracicaBronchiairway stentingBronchoscopymedicineHumansIn patientLung cancerAgedRetrospective StudiesAged 80 and overLungmedicine.diagnostic_testbusiness.industryPalliative CareGastroenterologyStentGranulation tissueGeneral Medicinerespiratory systemMiddle Agedmedicine.diseaseequipment and suppliesrespiratory tract diseasesAirway ObstructionStenosislung cancermedicine.anatomical_structureTreatment Outcomeairway stenosisFeasibility StudiesSurgeryFemaleStentsOriginal ArticleRadiologyCardiology and Cardiovascular MedicineAirwayChest radiographbusinessTracheal Stenosis
researchProduct

In-hospital mortality following lung cancer resection: nationwide administrative database.

2016

Our aim was to determine the effect of a national strategy for quality improvement in cancer management (the “Plan Cancer”) according to time period and to assess the influence of type and volume of hospital activity on in-hospital mortality (IHM) within a large national cohort of patients operated on for lung cancer.From January 2005 to December 2013, 76 235 patients were included in the French Administrative Database. Patient characteristics, hospital volume of activity and hospital type were analysed over three periods: 2005–2007, 2008–2010 and 2011–2013.Global crude IHM was 3.9%: 4.3% during 2005–2007, 4% during 2008–2010 and 3.5% during 2011–2013 (p&lt;0.01). 296, 259 and 209 centres p…

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPathologyLung NeoplasmsSurvivalDatabases FactualMEDLINEOperative Mortality030204 cardiovascular system & hematologyResectionCohort Studies03 medical and health sciences0302 clinical medicineAdministrative databaseInternal medicineMedicineHumansHospital MortalityLung cancerPneumonectomyLungAgedIn hospital mortalitybusiness.industryVolumeData CollectionCancerMiddle Agedmedicine.diseaseQualityHospitalsManagementComorbidity IndexHospitalization030228 respiratory systemOutcome IndicatorsCancer managementLobectomySurgeryFemaleFranceTrendsbusiness[ SDV.MHEP.PSR ] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractCohort studyThe European respiratory journal
researchProduct